(UTMD) Utah Medical Products, Inc. BCG Matrix Research |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
(UTMD) Utah Medical Products, Inc. Complete Analysis Pack
Download Your Competitive Advantage
This Utah Medical Products, Inc. BCG Matrix helps you see how the company’s products or business units may fit into the four classic quadrants: Stars, Cash Cows, Question Marks, and Dogs. What you see on this page is a real preview of the actual analysis, so you can review the format and content before buying. Purchase the full version to get the complete ready-to-use report.
Stars
LETZ cervical excision system
UTMD’s LETZ cervical excision system serves outpatient cervical lesion treatment, a women’s health niche with recurring demand for electrosurgical disposables and accessories. In FY2025, UTMD reported about $43 million in net sales, and LETZ can keep scaling without a broad hospital footprint.
That makes LETZ a stronger growth candidate in the portfolio: it fits minimally invasive care, has repeat-use economics, and benefits as outpatient procedure adoption rises.
FINESSE+ generator and electrodes
FINESSE+ fits a Star profile because it supports the LETZ workflow in the same gynecology procedure set, so each capital placement can pull through recurring electrode sales. That mix matters: the generator builds installed base, and the electrodes drive repeat revenue, which is exactly how platform tools scale in a growing niche.
Femcare laparoscopic instruments
Femcare laparoscopic instruments sit in UTMD’s Stars bucket: trocars and cannulae ride the still-expanding minimally invasive surgery market, which recent industry estimates put above $60 billion in 2025. These are procedure-linked tools, so hospitals and clinics reorder them with each laparoscopic gynecology case. With UTMD’s women’s health brand depth, the line has real cross-sell and growth runway.
FILTRESSE evacuators
FILTRESSE evacuators support electrosurgical smoke and plume control in gynecologic procedures, a need that grows as more care shifts to office-based and minimally invasive settings. For Utah Medical Products, Inc., it is a focused add-on to the women’s health line, with upside from cross-selling and broader procedure use.
- Links to smoke and plume control
- Fits minimally invasive gynecology
- Small now, expandable later
LUMIN uterine manipulator
LUMIN fits Utah Medical Products, Inc.’s niche-tool model: it sells a specialized uterine manipulator into laparoscopic gynecologic surgery, a field still taking share from open procedures. UTMD does not separately disclose LUMIN revenue, but the product can matter more as procedure volumes rise and adoption widens across minimally invasive care. If usage keeps building, LUMIN can move from a small star to a stronger franchise.
- Laparoscopy keeps taking share.
- Matches UTMD’s specialized-tool strategy.
- Adoption can lift franchise value.
UTMD’s Star Products Drive Repeat-Use Growth in Women’s Health
UTMD’s Stars are its women’s health tools with repeat-use economics, led by LETZ, FINESSE+, Femcare laparoscopy tools, FILTRESSE, and LUMIN. In FY2025, Utah Medical Products, Inc. reported about $43 million in net sales, and these products fit the higher-growth, minimally invasive care mix. Their value comes from procedure-linked reorders and installed-base pull-through.
| Star | FY2025 signal |
|---|---|
| LETZ | Recurring disposables |
| FINESSE+ | Generator plus electrode pull-through |
| Femcare | Minimally invasive gynecology demand |
| FILTRESSE | Smoke control add-on |
| LUMIN | Laparoscopic uterine use |
What is included in the product
Detailed Word Document
Utah Medical Products’ BCG Matrix flags stable cash cows, niche growth bets, and minimal dog risk across its device portfolio.
Editable Excel File
Clean BCG Matrix for Utah Medical Products, Inc. to quickly spot pain points and prioritize moves.
Reference Sources
Provides a credible source trail for Utah Medical Products, Inc. that supports faster due diligence and more confident decisions.
Cash Cows
Filshie Clip System
Filshie Clip System is Utah Medical Products, Inc.'s best-known surgical contraception brand and a long-standing market leader. The sterilization market is mature, so growth is limited, but the brand still supports steady repeat demand and dependable cash generation. In FY2025, its cash-cow role stayed intact: low-growth, high-recognition, and margin-supportive for Utah Medical Products, Inc.
DELTRAN PLUS pressure transducers
DELTRAN PLUS pressure transducers are used for invasive blood pressure monitoring, a core ICU and operating-room workflow that runs 24/7. That makes it a mature disposable line with steady replacement demand and limited customer switching. In Utah Medical Products, Inc.'s BCG Matrix, this fits a cash cow: stable volume, deep clinical embedding, and efficient cash generation.
DISPOSA-HOOD neonatal respiratory hood
DISPOSA-HOOD is a long-running neonatal respiratory hood used in NICUs, so it fits Utah Medical Products, Inc.'s Cash Cows bucket: a niche, stable market with repeat buying. Utah Medical Products, Inc. said neonatal and obstetric products remain a core line, and its 2025 Form 10-K showed 2025 revenue of $40.8 million, with the business still driven by established disposable products. That lets Utah Medical Products, Inc. keep harvesting cash from a mature item with limited growth but steady demand.
GESCO umbilical vessel catheters
GESCO umbilical vessel catheters fit Cash Cow status for Utah Medical Products, Inc.: they serve neonatal ICU and labor and delivery, where use is steady and replacement demand is recurring. The line is niche, so growth is limited, but utilization stays dependable.
- Recurring consumable demand
- Neonatal and L&D use
- Low market expansion
- Steady brand utilization
This makes the business more about cash generation than expansion, with value driven by repeat orders rather than big market share gains.
HEMO-NATE disposable filters
HEMO-NATE disposable filters fit UTMD’s cash-cow bucket: a mature, procedure-support product where reliability matters more than new features. In a low-growth niche, the line should keep throwing off steady cash while needing limited reinvestment, which helps fund UTMD’s other businesses. The latest 2025/2026 filing data should be checked for line-level sales, but the strategic role is clear.
- 成熟, low-growth disposable line
- Reliability beats innovation here
- Steady cash flow for UTMD
Utah Medical’s Cash Cows: Steady Sales, Strong Cash Flow
Utah Medical Products, Inc.'s Cash Cows are mature disposable lines that keep selling with little reinvestment. In FY2025, Company revenue was $40.8 million, and products like Filshie Clip, DELTRAN PLUS, DISPOSA-HOOD, GESCO, and HEMO-NATE kept cash flow steady through recurring clinical use.
| Item | FY2025 role |
|---|---|
| Filshie Clip | Market leader |
| DELTRAN PLUS | ICU repeat demand |
| DISPOSA-HOOD | NICU recurring use |
| GESCO | Neonatal steady demand |
| HEMO-NATE | Mature disposable |
Preview the Actual Deliverable
Utah Medical Products, Inc. Reference Sources
You’re previewing the exact Utah Medical Products, Inc. BCG Matrix document you’ll receive after purchase. The full file is the same professionally formatted report shown here—no changes, no hidden sections, no demo content. Once purchased, it’s ready for immediate use in analysis, presentations, or strategic planning.
Dogs
DIALY-NATE peritoneal dialysis sets
DIALY-NATE peritoneal dialysis sets fit the Dogs quadrant for Utah Medical Products, Inc. because the product serves a narrow disposable niche with limited scale and steady price pressure. The market is small, so growth stays muted and share is modest versus larger dialysis platforms. That makes it a low-growth, low-share item with weak BCG upside.
URI-CATH urinary drainage systems
URI-CATH urinary drainage systems are standard, low-differentiation products, so pricing power is usually weak and commoditization risk is high. In Utah Medical Products, Inc.'s BCG view, that makes the line a likely Dog if it does not defend share with clear clinical or service advantages. For a product like this, small price cuts can quickly pressure margins.
NUTRI-CATH and NUTRI-LOK feeding devices
NUTRI-CATH and NUTRI-LOK sit in a mature enteral feeding niche where demand is steady but growth is usually low single digits. In UTMD fiscal 2025, that kind of product mix supports cash flow, but not a big share jump. Without clear scale or dominance, these devices can absorb sales and support costs while returning only modest upside.
PATHFINDER PLUS endoscopic irrigation
PATHFINDER PLUS endoscopic irrigation fits a Dogs/Question-Mark profile: niche use, limited adoption, and no sign it is a growth engine for Utah Medical Products, Inc. In UTMD’s FY2025 results, net sales were about $43.6 million, but the company still centers on core women’s health products, not this procedural item.
- Low share in a narrow niche
- Limited pull versus core brands
- More holdover than growth asset
Catheterization procedure trays
Catheterization procedure trays are low-differentiation items, and hospitals usually choose them on price and convenience. For Utah Medical Products, Inc., that points to Dog territory in BCG terms unless FY2025 scale and cost control clearly lift margins and cash flow; otherwise, the line is useful, but not a growth driver.
- Price-led buying keeps differentiation weak
- Scale is the main way out of Dog status
UTMD’s Dogs: Cash-Generating, Low-Growth Niches
UTMD’s Dogs are small, mature product lines with weak pricing power and limited share, so they add cash but little growth. In FY2025, UTMD reported net sales of about $43.6 million, and these niches stayed tied to low-growth demand. That makes them more of a harvest-and-control group than a capital priority.
| Dog line | FY2025 view | BCG signal |
|---|---|---|
| DIALY-NATE | Niche, low share | Dog |
| URI-CATH | Commodity risk | Dog |
| NUTRI-CATH / NUTRI-LOK | Mature, steady demand | Dog |
Question Marks
LIBERTY urinary incontinence systems
LIBERTY urinary incontinence systems fit as a Question Mark: female incontinence affects roughly 25% to 45% of women, so the need is real and can grow, but market share is less proven than Utah Medical Products, Inc. legacy brands. The addressable market is attractive, yet scaling will likely need more spend, sales reach, and clinical adoption to win share.
TVUS/HSG-Cath uterine assessment products
UTMD’s TVUS/HSG-Cath uterine assessment products support diagnostic and fertility procedures, so demand should track more outpatient gynecology and reproductive care. The line fits a Question Mark because UTMD’s share is not clearly dominant, even if the market can expand with higher procedure volumes. For BCG, this is a growth bet that needs sharper sales push or product pull-through to avoid staying niche.
MYELO-NATE lumbar sampling kits
MYELO-NATE lumbar sampling kits fit the Question Mark slot: a specialized newborn product with a narrow clinical use case and limited visible scale. Utah Medical Products does not disclose a 2026 unit run rate for MYELO-NATE, so broad market leadership is not proven. The niche could grow, but current evidence still points to low share and uncertain volume.
PALA-NATE oral protection devices
PALA-NATE is a niche neonatal oral protection device, and UTMD’s 2025 filings do not break out its revenue separately. That lack of scale, plus its narrow use case, makes it look more like a Question Mark than a core growth engine beside UTMD’s larger franchises.
- Pediatric niche, not broad demand
- Useful product, limited scale
- Not disclosed as a separate revenue driver
- Fits Question Mark, not Star
Vacuum-assisted delivery accessories
Vacuum-assisted delivery accessories can gain from labor-and-delivery procedure volume, but Utah Medical Products, Inc. still faces a crowded hospital-buying market. In FY2025, UTMD remained a small-scale niche player, so this line has limited pricing power unless adoption rises. One line: volume helps, but share still decides the upside.
- Volume tailwind from deliveries
- Competition limits share gains
- Hospital adoption drives outcomes
- More investment may be needed
UTMD’s FY2025 Question Marks: Niche growth bets with unclear upside
UTMD’s Question Marks are niche, low-disclosure growth bets in FY2025. LIBERTY, TVUS/HSG-Cath, MYELO-NATE, PALA-NATE, and vacuum-assisted delivery accessories all face real demand, but UTMD does not show clear share dominance or separate revenue for most lines, so upside depends on adoption, sales reach, and hospital buying.
| Product | FY2025 signal | BCG read |
|---|---|---|
| LIBERTY | Growing need, share unclear | Question Mark |
| MYELO-NATE | Niche use, no run rate | Question Mark |
| PALA-NATE | No separate revenue | Question Mark |
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.